Molecular Biology Networks and Key Gene Regulators for Inflammatory Biomarkers Shared by Breast Cancer Development:...

Area of Science:

• Genomics
• Molecular Biology
• Cancer Research

Background:

• C-reactive protein (CRP) and interleukin-6 (IL6) are key inflammatory biomarkers implicated in non-inflammatory diseases, including breast cancer (BC).
• Previous genome-wide association studies (GWASs) have not fully explained the genetic heritability or regulatory mechanisms of CRP/IL6 and their link to BC.
• A comprehensive understanding of shared genetic underpinnings is needed for developing targeted preventive and therapeutic strategies.

Purpose of the Study:

• To integrate multi-omics data with GWAS findings to identify shared genetic regulatory mechanisms between CRP/IL6 and BC.
• To detect tissue-specific key drivers (KDs) involved in the pathogenesis of both CRP/IL6 regulation and BC risk.
• To uncover novel genetic targets for the prevention and treatment of BC and other associated disorders.

Main Methods:

• An integrative genomic network approach combining GWAS data for CRP/IL6 with whole-blood expression quantitative loci, pathways, and gene regulatory networks.
• Systematic genomics analysis for BC development to identify shared gene sets in enriched subnetworks.
• Gene-gene interaction network analysis to identify key drivers (KDs) in shared pathways.

Main Results:

• Identified significant common pathways shared between CRP/IL6 and BC, including immune regulation, chemokine signaling, and JAK-STAT signaling.
• Detected tissue-specific key drivers (KDs) in gene-gene interaction networks, including well-established (JAK1/2/3, STAT3) and novel (CXCR3, CD3D, CD3G, STAT6) players.
• Established shared mechanisms regulating CRP/IL6 and BC risk through identified KDs.

Conclusions:

• The study provides comprehensive insights into the regulatory mechanisms of CRP/IL6 and their shared genetic basis with BC.
• Identified novel genetic targets (KDs) that could be leveraged for preventive and therapeutic strategies against BC and related conditions.
• Highlights the utility of integrative genomic network approaches for dissecting complex disease etiologies.